News


Poseida Therapeutics Appoints Two Independent Directors, Adding Leaders for Compensation and Governance Functions

SAN DIEGO, Jan. 04, 2019 (GLOBE NEWSWIRE) — Poseida Therapeutics Inc., a clinical-stage biopharmaceutical company leveraging proprietary non-viral gene engineering technologies to create life-saving therapeutics, today announced the expansion of its board of directors with the appointment of Catherine J. Mackey, Ph.D., who will chair Poseida‚Äôs compensation committee, and Marcea Bland Lloyd, J.D., who will chair the nominating and governance committee.